Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 25, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 18, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results
August 09, 2022 16:01 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit
August 08, 2022 16:30 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer
August 02, 2022 07:30 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
July 28, 2022 16:06 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Systems, Inc. to Report Second Quarter 2022 Financial Results on August 9, 2022
July 28, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and...
Singular Genomics and Olink Collaborate to Enable Olink® Explore on the G4 Max Read™ Sequencing Kits
June 07, 2022 08:00 ET
|
Singular Genomics Systems, Inc.
Max Read kits on the G4 Sequencing Platform will produce up to 4 billion reads per run, enabling high throughput, cost-effective proteomics researchOlink continues its pioneering efforts to enable...
Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform
June 06, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, June 06, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems Inc. (Nasdaq: OMIC) and TwinStrand Biosciences, Inc. today announced a collaboration to develop highly sensitive next...
Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
June 03, 2022 08:00 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, June 03, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...